We use cookies to collect information, and enable our website to work properly. Please tell us whether you accept cookies by clicking the button below. If you decide not to accept cookies, our site may not work as expected and some information may not be available.
Click here for more information on cookies, including how to remove them.
GenQA supports truly global participation by accepting EQA submissions in English, French, German, Italian, Polish, Portuguese, and Spanish - breaking language barriers to ensure accessible, high-quality genomic assessment worldwide.
GenQA has extensive experience in providing haematological neoplasm EQAs for the past 20 years. These EQAs cover the common chronic and acute disorders including ALL, AML, CML, CLL, MDS, MPD, myeloma and lymphoma. To meet the needs of our participants, a range of sample types (online images, fixed cells, FFPE slides and DNA) and techniques (karyotyping, FISH, array/NGS and DNA mutation status) are included. In addition, participants can expect a broad range of referral types and abnormalities to analyse and report reflecting routine clinical practice.
We work closely with our colleagues in UK NEQAS Leucocyte Immunophenotyping (UK NEQAS LI) to deliver EQAs where the expert knowledge from both GenQA and UK NEQAS LI is beneficial to the delivery of the assessments.
Summary Information:
Assess the quality of testing and reporting of a broad range of haematological neoplasms, using various sample types and/or online case scenarios.
Based on real clinical cases, using validated samples.
Various sample types provided and any suitable techniques used.
6-12 weeks to submit the results.
Submitted laboratory reports are assessed, by an expert scientific panel, using international guidelines/recommendations.
Each participant receives an Individual Laboratory report (ILR) and EQA summary report detailing general findings, a summary of methodologies used, common errors and benchmarking against other laboratories worldwide.
Offers:
Enrol in 4 accredited Haematological Neoplasms EQAs: Add Classification of Haematological neoplasm variants EQA (VHC) for FREE!
Acute Lymphoblastic Leukaemia (ALL) (HALL)
Analysis and interpretation of recurrent and non-recurrent abnormalities associated with acute lymphoblastic leukaemia.
Presentation at a haematology clinic of an individual with haematological problems/neoplasia and a positive family history. NGS analysis of haematological samples for recurrent genomic abnormalities associated with inheritable bone marrow failure syndromes. For analysis of follow up germline samples, please see the Inherited cytopenias EQA.
NEWSLETTER SIGN UP